Press Releases
Search
-
07 May 2021
bioMérieux announces the CE marking of the new generation semi-quantitative VIDAS® SARS-COV-2 IgG II serology test.
bioMérieux, a world leader in the field of in vitro diagnostics, today announces CE marking of the new generation of IgG serology test with VIDAS® SARS-COV-2 IgG II to semi-quantitatively detect antib...
-
30 Apr 2021
bioMérieux announces CE-marking of the new MALDI-TOF mass spectrometry identification system: VITEK® MS PRIME
bioMérieux, a world leader in the field of in vitro diagnostics, has announced the CE-marking of VITEK® MS PRIME, the next generation of the VITEK® MS MALDI-TOF mass spectrometry system for routine mi...
-
27 Apr 2021
bioMérieux – First-Quarter 2021 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the three months ended March 31, 2021.
-
21 Apr 2021
bioMérieux - First Quarter 2011 Business Review
Marcy L'Etoile, France - April 21, 2011. Sales growth: 3.5% like-for-like Strong momentum in North America Temporary slowdown in China and India Robust growth in clinical microbiology 2011 sales growt...
-
07 Apr 2021
bioMérieux announces the CE marking of 3 dengue immunoassays on VIDAS®
bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated assays to diagnose dengue infection: VIDAS® DENGUE NS1 Ag VIDAS® Anti-DE...
-
24 Mar 2021
bioMérieux announces the CE marking of TB IGRA® test on VIDAS®
Today marks World Tuberculosis (TB) Day and bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated test VIDAS® TB IGRA (Interfe...